Stanley J. Wiegand - Publications

Regeneron, Rensselaer, NY, United States 
Neurotrophins, neuroanatomy

88 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Wei K, Piecewicz SM, McGinnis LM, Taniguchi CM, Wiegand SJ, Anderson K, Chan CW, Mulligan KX, Kuo D, Yuan J, Vallon M, Morton LC, Lefai E, Simon MC, Maher JJ, et al. A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition. Nature Medicine. 19: 1331-7. PMID 24037094 DOI: 10.1038/nm.3295  0.4
2012 Fraser HM, Hastings JM, Allan D, Morris KD, Rudge JS, Wiegand SJ. Inhibition of delta-like ligand 4 induces luteal hypervascularization followed by functional and structural luteolysis in the primate ovary. Endocrinology. 153: 1972-83. PMID 22334711 DOI: 10.1210/en.2011-1688  0.72
2012 Papadopoulos N, Martin J, Ruan Q, Rafique A, Rosconi MP, Shi E, Pyles EA, Yancopoulos GD, Stahl N, Wiegand SJ. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis. 15: 171-85. PMID 22302382 DOI: 10.1007/s10456-011-9249-6  0.44
2011 Lobov IB, Cheung E, Wudali R, Cao J, Halasz G, Wei Y, Economides A, Lin HC, Papadopoulos N, Yancopoulos GD, Wiegand SJ. The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow. Blood. 117: 6728-37. PMID 21498671 DOI: 10.1182/blood-2010-08-302067  0.44
2010 Cao J, Zhao L, Li Y, Liu Y, Xiao W, Song Y, Luo L, Huang D, Yancopoulos GD, Wiegand SJ, Wen R. A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap. Investigative Ophthalmology & Visual Science. 51: 6009-17. PMID 20538989 DOI: 10.1167/iovs.09-4956  0.44
2007 Rudge JS, Holash J, Hylton D, Russell M, Jiang S, Leidich R, Papadopoulos N, Pyles EA, Torri A, Wiegand SJ, Thurston G, Stahl N, Yancopoulos GD. VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade. Proceedings of the National Academy of Sciences of the United States of America. 104: 18363-70. PMID 18000042 DOI: 10.1073/pnas.0708865104  0.72
2007 Kasselman LJ, Kintner J, Sideris A, Pasnikowski E, Krellman JW, Shah S, Rudge JS, Yancopoulos GD, Wiegand SJ, Croll SD. Dexamethasone treatment and ICAM-1 deficiency impair VEGF-induced angiogenesis in adult brain. Journal of Vascular Research. 44: 283-91. PMID 17406120 DOI: 10.1159/000101450  0.72
2007 Torres R, Croll SD, Vercollone J, Reinhardt J, Griffiths J, Zabski S, Anderson KD, Adams NC, Gowen L, Sleeman MW, Valenzuela DM, Wiegand SJ, Yancopoulos GD, Murphy AJ. Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses. Pain. 130: 267-78. PMID 17379411 DOI: 10.1016/j.pain.2007.01.036  0.6
2007 Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, Wiegand SJ. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proceedings of the National Academy of Sciences of the United States of America. 104: 3219-24. PMID 17296940 DOI: 10.1073/pnas.0611206104  0.44
2006 Fraser HM, Wilson H, Wulff C, Rudge JS, Wiegand SJ. Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. Reproduction (Cambridge, England). 132: 589-600. PMID 17008470 DOI: 10.1530/rep.1.01064  0.72
2006 Kasselman LJ, Sideris A, Bruno C, Perez WR, Cai N, Nicoletti JN, Wiegand SJ, Croll SD. BDNF: a missing link between sympathetic dysfunction and inflammatory disease? Journal of Neuroimmunology. 175: 118-27. PMID 16631934 DOI: 10.1016/j.jneuroim.2006.03.008  0.56
2005 Rudge JS, Thurston G, Davis S, Papadopoulos N, Gale N, Wiegand SJ, Yancopoulos GD. VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets. Cold Spring Harbor Symposia On Quantitative Biology. 70: 411-8. PMID 16869778 DOI: 10.1101/sqb.2005.70.052  0.72
2005 Wortley KE, Anderson KD, Yasenchak J, Murphy A, Valenzuela D, Diano S, Yancopoulos GD, Wiegand SJ, Sleeman MW. Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metabolism. 2: 421-7. PMID 16330327 DOI: 10.1016/j.cmet.2005.11.004  0.6
2005 Macdonald LE, Wortley KE, Gowen LC, Anderson KD, Murray JD, Poueymirou WT, Simmons MV, Barber D, Valenzuela DM, Economides AN, Wiegand SJ, Yancopoulos GD, Sleeman MW, Murphy AJ. Resistance to diet-induced obesity in mice globally overexpressing OGH/GPB5. Proceedings of the National Academy of Sciences of the United States of America. 102: 2496-501. PMID 15699348 DOI: 10.1073/pnas.0409849102  0.6
2005 Sleeman MW, Wortley KE, Lai KM, Gowen LC, Kintner J, Kline WO, Garcia K, Stitt TN, Yancopoulos GD, Wiegand SJ, Glass DJ. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nature Medicine. 11: 199-205. PMID 15654325 DOI: 10.1038/nm1178  0.72
2005 Thurston G, Rudge JS, Ioffe E, Papadopoulos N, Daly C, Vuthoori S, Daly T, Wiegand SJ, Yancopoulos GD. The anti-inflammatory actions of angiopoietin-1. Exs. 233-45. PMID 15617482  0.72
2005 Fraser HM, Wilson H, Rudge JS, Wiegand SJ. Single injections of vascular endothelial growth factor trap block ovulation in the macaque and produce a prolonged, dose-related suppression of ovarian function. The Journal of Clinical Endocrinology and Metabolism. 90: 1114-22. PMID 15562010 DOI: 10.1210/jc.2004-1572  0.72
2004 Hutter R, Carrick FE, Valdiviezo C, Wolinsky C, Rudge JS, Wiegand SJ, Fuster V, Badimon JJ, Sauter BV. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation. 110: 2430-5. PMID 15477421 DOI: 10.1161/01.CIR.0000145120.37891.8A  0.72
2004 Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD, Wiegand SJ, Sleeman MW. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proceedings of the National Academy of Sciences of the United States of America. 101: 8227-32. PMID 15148384 DOI: 10.1073/pnas.0402763101  0.6
2004 Croll SD, Ransohoff RM, Cai N, Zhang Q, Martin FJ, Wei T, Kasselman LJ, Kintner J, Murphy AJ, Yancopoulos GD, Wiegand SJ. VEGF-mediated inflammation precedes angiogenesis in adult brain. Experimental Neurology. 187: 388-402. PMID 15144865 DOI: 10.1016/j.expneurol.2004.02.010  0.56
2004 Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Dana MR, Wiegand SJ, Streilein JW. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. The Journal of Clinical Investigation. 113: 1040-50. PMID 15057311 DOI: 10.1172/JCI20465  0.56
2003 Sleeman MW, Garcia K, Liu R, Murray JD, Malinova L, Moncrieffe M, Yancopoulos GD, Wiegand SJ. Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice. Proceedings of the National Academy of Sciences of the United States of America. 100: 14297-302. PMID 14610276 DOI: 10.1073/pnas.2335926100  0.44
2003 Anderson KD, Lambert PD, Corcoran TL, Murray JD, Thabet KE, Yancopoulos GD, Wiegand SJ. Activation of the hypothalamic arcuate nucleus predicts the anorectic actions of ciliary neurotrophic factor and leptin in intact and gold thioglucose-lesioned mice. Journal of Neuroendocrinology. 15: 649-60. PMID 12787049 DOI: 10.1046/j.1365-2826.2003.01043.x  0.6
2003 Saishin Y, Saishin Y, Takahashi K, Lima e Silva R, Hylton D, Rudge JS, Wiegand SJ, Campochiaro PA. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. Journal of Cellular Physiology. 195: 241-8. PMID 12652651 DOI: 10.1002/jcp.10246  0.72
2003 Joussen AM, Poulaki V, Mitsiades N, Stechschulte SU, Kirchhof B, Dartt DA, Fong GH, Rudge J, Wiegand SJ, Yancopoulos GD, Adamis AP. VEGF-dependent conjunctivalization of the corneal surface. Investigative Ophthalmology & Visual Science. 44: 117-23. PMID 12506063 DOI: 10.1167/iovs.01-1277  0.72
2002 Gale NW, Thurston G, Davis S, Wiegand SJ, Holash J, Rudge JS, Yancopoulos GD. Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation. Cold Spring Harbor Symposia On Quantitative Biology. 67: 267-73. PMID 12858549  0.72
2002 Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, Honda Y, Wiegand SJ, Yancopoulos GD, Nishikawa S. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. The Journal of Clinical Investigation. 110: 1619-28. PMID 12464667 DOI: 10.1172/JCI15621  0.44
2002 Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Developmental Cell. 3: 411-23. PMID 12361603 DOI: 10.1016/S1534-5807(02)00217-4  0.44
2002 Holash J, Davis S, Papadopoulos N, Croll SD, Ho L, Russell M, Boland P, Leidich R, Hylton D, Burova E, Ioffe E, Huang T, Radziejewski C, Bailey K, Fandl JP, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proceedings of the National Academy of Sciences of the United States of America. 99: 11393-8. PMID 12177445 DOI: 10.1073/pnas.172398299  0.72
2002 Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology. 143: 2797-807. PMID 12072415 DOI: 10.1210/endo.143.7.8886  0.72
2002 Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, Moromizato Y, Bursell SE, Wiegand SJ, Rudge J, Ioffe E, Yancopoulos GD, Adamis AP. Suppression of diabetic retinopathy with angiopoietin-1. The American Journal of Pathology. 160: 1683-93. PMID 12000720 DOI: 10.1016/S0002-9440(10)61115-7  0.72
2002 Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. The Journal of Clinical Investigation. 109: 805-15. PMID 11901189 DOI: 10.1172/JCI13776  0.72
2002 Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. The American Journal of Pathology. 160: 501-9. PMID 11839570 DOI: 10.1016/S0002-9440(10)64869-9  0.72
2001 Croll SD, Wiegand SJ. Vascular growth factors in cerebral ischemia. Molecular Neurobiology. 23: 121-35. PMID 11817215 DOI: 10.1385/MN:23:2-3:121  0.56
2001 Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Investigative Ophthalmology & Visual Science. 42: 2408-13. PMID 11527957  0.72
2001 Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF, Fraser HM. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). The Journal of Clinical Endocrinology and Metabolism. 86: 3377-86. PMID 11443214 DOI: 10.1210/jcem.86.7.7662  0.72
2001 Lambert PD, Anderson KD, Sleeman MW, Wong V, Tan J, Hijarunguru A, Corcoran TL, Murray JD, Thabet KE, Yancopoulos GD, Wiegand SJ. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proceedings of the National Academy of Sciences of the United States of America. 98: 4652-7. PMID 11259650 DOI: 10.1073/pnas.061034298  0.6
2000 Zagzag D, Friedlander DR, Margolis B, Grumet M, Semenza GL, Zhong H, Simons JW, Holash J, Wiegand SJ, Yancopoulos GD. Molecular events implicated in brain tumor angiogenesis and invasion. Pediatric Neurosurgery. 33: 49-55. PMID 11025423  0.72
2000 Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 407: 242-8. PMID 11001067 DOI: 10.1038/35025215  0.72
2000 Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand SJ, Zabski S, Yancopoulos GD, Grumet M. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 80: 837-49. PMID 10879735  0.72
2000 Sleeman MW, Anderson KD, Lambert PD, Yancopoulos GD, Wiegand SJ. The ciliary neurotrophic factor and its receptor, CNTFR alpha. Pharmaceutica Acta Helvetiae. 74: 265-72. PMID 10812968 DOI: 10.1016/S0031-6865(99)00050-3  0.6
1999 Croll SD, Chesnutt CR, Greene NA, Lindsay RM, Wiegand SJ. Peptide immunoreactivity in aged rat cortex and hippocampus as a function of memory and BDNF infusion. Pharmacology, Biochemistry, and Behavior. 64: 625-35. PMID 10548280 DOI: 10.1016/S0091-3057(99)00122-7  0.72
1999 Zagzag D, Hooper A, Friedlander DR, Chan W, Holash J, Wiegand SJ, Yancopoulos GD, Grumet M. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Experimental Neurology. 159: 391-400. PMID 10506510 DOI: 10.1006/exnr.1999.7162  0.72
1999 Croll SD, Suri C, Compton DL, Simmons MV, Yancopoulos GD, Lindsay RM, Wiegand SJ, Rudge JS, Scharfman HE. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience. 93: 1491-506. PMID 10501474 DOI: 10.1016/S0306-4522(99)00296-1  0.72
1999 Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene. 18: 5356-62. PMID 10498889 DOI: 10.1038/sj.onc.1203035  0.44
1999 Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science (New York, N.Y.). 284: 1994-8. PMID 10373119 DOI: 10.1126/science.284.5422.1994  0.72
1999 Tonra JR, Ono M, Liu X, Garcia K, Jackson C, Yancopoulos GD, Wiegand SJ, Wong V. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes. 48: 588-94. PMID 10078561  0.72
1998 Croll SD, Ip NY, Lindsay RM, Wiegand SJ. Expression of BDNF and trkB as a function of age and cognitive performance. Brain Research. 812: 200-8. PMID 9813325 DOI: 10.1016/S0006-8993(98)00993-7  0.72
1998 Croll SD, Chesnutt CR, Rudge JS, Acheson A, Ryan TE, Siuciak JA, DiStefano PS, Wiegand SJ, Lindsay RM. Co-infusion with a TrkB-Fc receptor body carrier enhances BDNF distribution in the adult rat brain. Experimental Neurology. 152: 20-33. PMID 9682009 DOI: 10.1006/exnr.1998.6836  0.72
1998 Yurek DM, Hipkens SB, Wiegand SJ, Altar CA. Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenic appearance of BDNF in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 6040-7. PMID 9671688  0.6
1998 Zigova T, Pencea V, Betarbet R, Wiegand SJ, Alexander C, Bakay RA, Luskin MB. Neuronal progenitor cells of the neonatal subventricular zone differentiate and disperse following transplantation into the adult rat striatum. Cell Transplantation. 7: 137-56. PMID 9588596 DOI: 10.1016/S0963-6897(98)00009-8  0.56
1998 Rudge JS, Mather PE, Pasnikowski EM, Cai N, Corcoran T, Acheson A, Anderson K, Lindsay RM, Wiegand SJ. Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective. Experimental Neurology. 149: 398-410. PMID 9500963 DOI: 10.1006/exnr.1997.6737  0.72
1997 Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389: 856-60. PMID 9349818 DOI: 10.1038/39885  0.72
1997 Kawahara N, Croll SD, Wiegand SJ, Klatzo I. Cortical spreading depression induces long-term alterations of BDNF levels in cortex and hippocampus distinct from lesion effects: implications for ischemic tolerance. Neuroscience Research. 29: 37-47. PMID 9293491 DOI: 10.1016/S0168-0102(97)00069-2  0.56
1997 Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (New York, N.Y.). 277: 55-60. PMID 9204896 DOI: 10.1126/science.277.5322.55  0.72
1997 Frank L, Wiegand SJ, Siuciak JA, Lindsay RM, Rudge JS. Effects of BDNF infusion on the regulation of TrkB protein and message in adult rat brain. Experimental Neurology. 145: 62-70. PMID 9184109 DOI: 10.1006/exnr.1997.6440  0.72
1997 Helgren ME, Cliffer KD, Torrento K, Cavnor C, Curtis R, DiStefano PS, Wiegand SJ, Lindsay RM. Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 372-82. PMID 8987762  0.72
1997 Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacology, Biochemistry, and Behavior. 56: 131-7. PMID 8981620 DOI: 10.1016/S0091-3057(96)00169-4  0.72
1996 Jones BE, Boylan CB, Fritsche M, Juhasz M, Jackson C, Wiegand SJ, Hyman C, Lindsay RM, Altar CA. A continuous striatal infusion of 6-hydroxydopamine produces a terminal axotomy and delayed behavioral effects. Brain Research. 709: 275-84. PMID 8833764 DOI: 10.1016/0006-8993(95)01322-9  0.72
1996 Alderson RF, Wiegand SJ, Anderson KD, Cai N, Cho JY, Lindsay RM, Altar CA. Neurotrophin-4/5 maintains the cholinergic phenotype of axotomized septal neurons. The European Journal of Neuroscience. 8: 282-90. PMID 8714699  0.72
1996 Anderson KD, Panayotatos N, Corcoran TL, Lindsay RM, Wiegand SJ. Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proceedings of the National Academy of Sciences of the United States of America. 93: 7346-51. PMID 8692996 DOI: 10.1073/pnas.93.14.7346  0.72
1995 Anderson KD, Alderson RF, Altar CA, DiStefano PS, Corcoran TL, Lindsay RM, Wiegand SJ. Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. The Journal of Comparative Neurology. 357: 296-317. PMID 7665731 DOI: 10.1002/cne.903570209  0.72
1995 Siuciak JA, Wong V, Pearsall D, Wiegand SJ, Lindsay RM. BDNF produces analgesia in the formalin test and modifies neuropeptide levels in rat brain and spinal cord areas associated with nociception. The European Journal of Neuroscience. 7: 663-70. PMID 7620617  0.72
1994 Fischer W, Sirevaag A, Wiegand SJ, Lindsay RM, Björklund A. Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proceedings of the National Academy of Sciences of the United States of America. 91: 8607-11. PMID 8078930  0.72
1994 Rudge JS, Li Y, Pasnikowski EM, Mattsson K, Pan L, Yancopoulos GD, Wiegand SJ, Lindsay RM, Ip NY. Neurotrophic factor receptors and their signal transduction capabilities in rat astrocytes. The European Journal of Neuroscience. 6: 693-705. PMID 8075814  0.72
1994 Sauer H, Campbell K, Wiegand SJ, Lindsay RM, Björklund A. Brain-derived neurotrophic factor enhances striatal neuropeptide expression in both the intact and the dopamine-depleted rat striatum. Neuroreport. 5: 609-12. PMID 8025254  0.72
1994 Altar CA, Siuciak JA, Wright P, Ip NY, Lindsay RM, Wiegand SJ. In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3. The European Journal of Neuroscience. 6: 1389-405. PMID 8000564  0.72
1994 Croll SD, Wiegand SJ, Anderson KD, Lindsay RM, Nawa H. Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. The European Journal of Neuroscience. 6: 1343-53. PMID 7981876 DOI: 10.1111/j.1460-9568.1994.tb00325.x  0.72
1994 Burke MA, Mobley WC, Cho J, Wiegand SJ, Lindsay RM, Mufson EJ, Kordower JH. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins. Experimental Neurology. 130: 178-95. PMID 7867749 DOI: 10.1006/exnr.1994.1197  0.72
1994 Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS. Neurotrophic factors: from molecule to man. Trends in Neurosciences. 17: 182-90. PMID 7520198 DOI: 10.1016/0166-2236(94)90099-X  0.72
1994 Altar CA, Boylan CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. Journal of Neurochemistry. 63: 1021-32. PMID 7519657  0.72
1994 Siuciak JA, Altar CA, Wiegand SJ, Lindsay RM. Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Research. 633: 326-30. PMID 7511037 DOI: 10.1016/0006-8993(94)91556-3  0.72
1993 Ip NY, McClain J, Barrezueta NX, Aldrich TH, Pan L, Li Y, Wiegand SJ, Friedman B, Davis S, Yancopoulos GD. The alpha component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development. Neuron. 10: 89-102. PMID 8381290  0.56
1993 Lindsay RM, Altar CA, Cedarbaum JM, Hyman C, Wiegand SJ. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Experimental Neurology. 124: 103-18. PMID 8282068 DOI: 10.1006/exnr.1993.1181  0.72
1993 Sauer H, Fischer W, Nikkhah G, Wiegand SJ, Brundin P, Lindsay RM, Björklund A. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Research. 626: 37-44. PMID 8281451 DOI: 10.1016/0006-8993(93)90560-A  0.72
1993 Ip NY, Wiegand SJ, Morse J, Rudge JS. Injury-induced regulation of ciliary neurotrophic factor mRNA in the adult rat brain. The European Journal of Neuroscience. 5: 25-33. PMID 8261087  0.72
1993 Morse JK, Wiegand SJ, Anderson K, You Y, Cai N, Carnahan J, Miller J, DiStefano PS, Altar CA, Lindsay RM. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 4146-56. PMID 8080477  0.72
1992 Friedman B, Scherer SS, Rudge JS, Helgren M, Morrisey D, McClain J, Wang DY, Wiegand SJ, Furth ME, Lindsay RM. Regulation of ciliary neurotrophic factor expression in myelin-related Schwann cells in vivo. Neuron. 9: 295-305. PMID 1497895 DOI: 10.1016/0896-6273(92)90168-D  0.72
1992 Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proceedings of the National Academy of Sciences of the United States of America. 89: 11347-51. PMID 1454818 DOI: 10.1073/pnas.89.23.11347  0.72
1992 DiStefano PS, Friedman B, Radziejewski C, Alexander C, Boland P, Schick CM, Lindsay RM, Wiegand SJ. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron. 8: 983-93. PMID 1375039 DOI: 10.1016/0896-6273(92)90213-W  0.72
1990 Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Furth ME, Lindsay RM, Yancopoulos GD. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron. 5: 501-9. PMID 1688327 DOI: 10.1016/0896-6273(90)90089-X  0.72
1989 Earnest DJ, Sladek CD, Gash DM, Wiegand SJ. Specificity of circadian function in transplants of the fetal suprachiasmatic nucleus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 2671-7. PMID 2769362  0.72
1980 Wiegand SJ, Terasawa E, Bridson WE, Goy RW. Effects of discrete lesions of preoptic and suprachiasmatic structures in the female rat. Alterations in the feedback regulation of gonadotropin secretion. Neuroendocrinology. 31: 147-57. PMID 6771669  0.72
1979 Terasawa E, King MK, Wiegand SJ, Bridson WE, Goy RW. Barbiturate anesthesia blocks the positive feedback effect of progesterone, but not of estrogen, on luteinizing hormone release in ovariectomized guinea pigs. Endocrinology. 104: 687-92. PMID 436727 DOI: 10.1210/endo-104-3-687  0.72
1978 Goldfoot DA, Wiegand SJ, Scheffler G. Continued copulation of ovariectomized adrenal-suppressed stumptail macaques (Macaca arctoides). Hormones and Behavior. 11: 89-99. PMID 107108 DOI: 10.1016/0018-506X(78)90060-0  0.72
1978 Slob AK, Wiegand SJ, Goy RW, Robinson JA. Heterosexual interactions in laboratory-housed stumptail macaques (Macaca arctoides): observations during the menstrual cycle and after ovariectomy. Hormones and Behavior. 10: 193-211. PMID 99358 DOI: 10.1016/0018-506X(78)90008-9  0.72
1975 Slob AK, Goy RW, Wiegand SJ, Scheffler G. Proceedings: Gonadal hormones and behaviour in the stumptail macaque (Macaca arctoides) under laboratory conditions: a preliminary report. The Journal of Endocrinology. 64: 38P-39P. PMID 1133524  0.72
1975 Goldfoot DA, Slob AK, Scheffler G, Robinson JA, Wiegand SJ, Cords J. Multiple ejaculations during prolonged sexual tests and lack of resultant serum testosterone increases in Male Stumptail Macaques (M. arctoides). Archives of Sexual Behavior. 4: 547-60. PMID 811192 DOI: 10.1007/BF01542133  0.72
Show low-probability matches.